Quick Answer
iRhythm Holdings, Inc. reported Research And Development Expense of $60.24 million for the year ending 2023.
- iRhythm Holdings, Inc. showed an increase of +29.3% in Research And Development Expense from 2022 to 2023.
- This data is from iRhythm Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 22, 2024.
- XBRL data for this metric is available from 2014 to 2023 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2014 to 2023), iRhythm Holdings, Inc.'s Research And Development Expense has grown by 957.3%.
- Historical annual values: Fiscal year 2023: $60.24 million | Fiscal year 2022: $46.61 million | Fiscal year 2021: $38.67 million | Fiscal year 2020: $41.33 million | Fiscal year 2019: $37.30 million | Fiscal year 2018: $20.86 million | Fiscal year 2017: $13.27 million | Fiscal year 2016: $7.15 million | Fiscal year 2015: $6.35 million | Fiscal year 2014: $5.70 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: